Quest Diagnostics vs Toyota: Founders, CEOs and History

Company facts

Founders

CEOs and their tenures

Timeline: Quest Diagnostics and Toyota side by side

1. 1937Toyota

   Toyota Motor Corporation incorporated

   Toyota Motor Corporation was incorporated after Kiichiro Toyoda expanded the Toyoda family business from automatic looms into automobile manufacturing.

2. 1955Toyota

   Toyopet Crown launched

   The Toyopet Crown gave Toyota a postwar passenger-car platform and later became its first passenger car exported to the United States.

3. 1966Toyota

   Corolla launched

   Toyota launched the Corolla, a compact car that became central to its mass-market export strategy.

4. 1967Quest Diagnostics

   Metropolitan Pathology Laboratory Founded by Dr. Paul A. Brown

   Dr. Paul A. Brown founded Metropolitan Pathology Laboratory, Inc. in Teaneck, New Jersey, to provide clinical laboratory services to local physicians and hospitals. The company was renamed MetPath, Inc. in 1969.

5. 1982Quest Diagnostics

   Corning Glass Works Acquires MetPath

   Corning Glass Works acquired MetPath and renamed it Corning Clinical Laboratories.

6. 1989Toyota

   Lexus launches

   Toyota launched Lexus with the LS 400, moving into premium vehicles with a quality-led strategy.

7. 1996Quest Diagnostics

   Spin-off from Corning as Independent Public Company

   On December 31, 1996, Quest Diagnostics became an independent company through a spin-off from Corning and began trading on the NYSE under ticker DGX. Kenneth W. Freeman was appointed CEO.

8. 1997Toyota

   Prius launches in Japan

   Toyota launched the Prius, turning hybrid technology into a mass-produced passenger vehicle.

9. 1999Quest Diagnostics

   Acquisition of SmithKline Beecham Clinical Laboratories

   Quest acquired SmithKline Beecham Clinical Laboratories for approximately $1.3 billion in cash and stock.

10. 2003Quest Diagnostics

    Acquisition of Unilab Corporation for $800 Million

    Quest acquired Unilab Corporation for $800 million, significantly expanding its West Coast presence and adding substantial volume in California and surrounding states.

11. 2005Quest Diagnostics

    Acquisition of LabOne, Inc. for $934 Million

    Quest acquired LabOne, Inc. for $934 million, adding employer drug testing and paramedical testing capabilities that expanded the company's service offerings beyond traditional clinical laboratory testing.

12. 2007Quest Diagnostics

    Acquisition of AmeriPath for Approximately $1.23 Billion

    Quest acquired AmeriPath and its subsidiary Specialty Laboratories for approximately $1.23 billion, adding anatomic pathology and cancer diagnostic testing capabilities that complemented Quest's clinical chemistry strengths.

13. 2011Quest Diagnostics

    Acquisitions of Athena Diagnostics and Celera Corporation

    Quest acquired Athena Diagnostics (neurodegenerative disease testing) and Celera Corporation (genomics and sequencing), adding advanced diagnostics capabilities in neurology and genetic testing that would become foundational for future growth initiatives.

14. 2014Quest Diagnostics

    Acquisition of Solstas Lab Partners Group for $570 Million

    Quest acquired Solstas Lab Partners Group for $570 million, expanding its geographic footprint in the Southeastern United States and adding hospital outreach laboratory relationships.

15. 2016Toyota

    Acquired Daihatsu Motor Co., Ltd.

    Toyota Motor acquired Daihatsu Motor Co., Ltd..

16. 2018Quest Diagnostics

    Launch of QuestDirect Consumer-Initiated Testing

    Quest launched QuestDirect, a consumer-initiated testing service that allows patients to order health and wellness lab testing without a physician order in states where permitted. This marked Quest's entry into the direct-to-consumer diagnostic market.

17. 2020Quest Diagnostics

    COVID-19 Testing Launch and Pandemic Response

    Quest launched COVID-19 testing in March 2020 and by July 2020 had performed more than 9.2 million molecular tests and 2.8 million serology tests. The pandemic created both operational challenges and substantial revenue opportunities for the company.

18. 2020Quest Diagnostics

    Acquisition of Blueprint Genetics for $108 Million

    Quest acquired Blueprint Genetics (Helsinki, Finland) for $108 million, adding genetic testing capabilities for rare diseases and expanding Quest's international genomics expertise.

19. 2021Toyota

    Acquired Lyft Level 5

    Toyota Motor acquired Lyft Level 5 for $550 million.

20. 2021Toyota

    Acquired CARMERA

    Toyota Motor acquired CARMERA.

21. 2022Quest Diagnostics

    Jim Davis Becomes CEO, Succeeding Steve Rusckowski

    Jim Davis succeeded Steve Rusckowski as CEO on November 1, 2022, after serving as Executive Vice President of General Diagnostics. Davis brought experience from GE Healthcare, InSightec, and McKinsey & Company. He became Chairman on April 1, 2023.

22. 2023Quest Diagnostics

    Acquisition of Haystack Oncology and NewYork-Presbyterian Outreach

    Quest acquired Haystack Oncology, a minimal residual disease testing company, and the outreach laboratory operations of NewYork-Presbyterian Hospital for $275 million, expanding advanced oncology diagnostics and health system partnerships.

23. 2024Quest Diagnostics

    Acquisition of LifeLabs from OMERS for CAD $1.35 Billion

    Quest completed the acquisition of LifeLabs from OMERS for approximately CAD $1.35 billion (USD ~$1 billion), adding Canada's leading laboratory diagnostic provider with 6,500+ employees, 8+ million online portal users, and approximately CAD $970 million in an…

24. 2025Quest Diagnostics

    Acquisition of Fresenius Medical Care Spectra Laboratories Assets

    Quest completed the acquisition of select clinical testing assets from Fresenius Medical Care's Spectra Laboratories and began providing comprehensive dialysis-related laboratory services for Fresenius-operated centers serving approximately 200,000 patients an…

25. 2025Quest Diagnostics

    Record Financial Performance and Raised 2026 Guidance

    Quest reported record 2025 results with $11.035 billion in revenue (up 11.8%), operating income of $1.556 billion (up 15.6%), and cash from operations of $1.886 billion (up 41.4%).

26. 2026Quest Diagnostics

    Q1 2026 Results Raise Guidance

    Quest Diagnostics reports Q1 2026 revenues of $2.895B, 9.0% organic revenue growth, and raises FY2026 net revenue guidance to $11.78B-$11.90B.

27. 2026Quest Diagnostics

    Q2 2026 Results and Second Guidance Raise

    Quest reported Q2 2026 revenue of $3.043B (up 10.2%, 10.0% organic) and adjusted diluted EPS of $3.12 (up 19.1%). It raised FY2026 revenue guidance to $11.95B-$12.05B. New York State approved Haystack MRD in the same period.

28. 2026Toyota

    Kenta Kon becomes president and CEO

    Kenta Kon became president and CEO on April 1, 2026, while Koji Sato moved to vice chairman and chief industry officer.

29. 2026Toyota

    FY2026 sales revenues reach ~$340B (JPY 50.685T)

    Toyota reported FY2026 sales revenues of ~$340 billion (JPY 50,684.952 billion) and net income attributable to Toyota Motor Corporation of ~$25.8 billion (JPY 3,848.098 billion).

Acquisitions

Questions about Quest Diagnostics vs Toyota